22 November 2017
News and Views
Links and Services
Oral medications with significant hepatic metabolism are at higher risk for hepatic adverse events, finds this month's issue of Hepatology.
Reactive metabolites generated by hepatic metabolism are thought to play an important role in the
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors